Company profile: NeoImmuneTech

BMS announces positive Reblozyl phase 3 results for MDS

Bristol Myers Squibb has announced positive topline results from its

Otonomy's hearing loss drug shows no benefit in trial, tanki...

Otonomy has chalked up its second clinical trial failure in the space of a few months, the latest in a mid-stage study of a treatment for hearing loss, and the biotech has now been forced i

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.

Oxford Uni scientists put Siga's Tpoxx to the test for monke...

The team at Oxford University behind the landmark RECOVERY trial of COVID-19 therapies now has monkeypox in its sights, with a study that will see if Siga Technologies' smallpox drug Tpoxx